Clinical Trial Update: Treating Depression in Coronary Artery Disease With Omega-3 Fatty Acids [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating omega-3 fatty acids for depression in patients with coronary artery disease has completed. The update does not include trial results in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Major Depressive Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Coronary Artery Disease, Depression | Phase 3 | Status: COMPLETED